Thursday, February 25th 2021 (17:00 - 18:00)


€0 for non-members

€0 for members



Organised by

Propharma Group



In the competitive and fast-moving Cell and Gene Therapy (CGT) field, developers face a range of scientific, technical, and regulatory challenges that can quickly become overwhelming and costly. In spite of this, CGT/ATMP holds great promise to deliver transformative outcomes for a wide range of traditionally hard-to-treat diseases.  

There are nearly 400 cell and gene therapies currently in development, representing a 20% increase from 2018. We will discuss how you can accelerate your CGT product development by creating a clear roadmap for achieving critical milestones that will benefit the patients who need them.  

Participants will gain a better understanding of:

  • Building an effective quality management system (QMS)

  • Designing the right nonclinical studies

  • Engaging regulators globally

Interested in learning more? Register today and join us for a live webinar!